Annual D&A
$8.00 M
+$2.00 M+33.33%
31 December 2023
Summary:
Arcus Biosciences annual depreciation & amortization is currently $8.00 million, with the most recent change of +$2.00 million (+33.33%) on 31 December 2023. During the last 3 years, it has risen by +$5.00 million (+166.67%). RCUS annual D&A is now at all-time high.RCUS Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$2.00 M
$0.000.00%
30 September 2024
Summary:
Arcus Biosciences quarterly depreciation & amortization is currently $2.00 million, unchanged on 30 September 2024. Over the past year, it has increased by +$1.00 million (+100.00%). RCUS quarterly D&A is now -33.33% below its all-time high of $3.00 million, reached on 31 December 2023.RCUS Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$10.00 M
+$1.00 M+11.11%
30 September 2024
Summary:
Arcus Biosciences TTM depreciation & amortization is currently $10.00 million, with the most recent change of +$1.00 million (+11.11%) on 30 September 2024. Over the past year, it has increased by +$4.00 million (+66.67%). RCUS TTM D&A is now at all-time high.RCUS TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RCUS Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +33.3% | +100.0% | +66.7% |
| 3 y3 years | +166.7% | +107.7% | +275.9% |
| 5 y5 years | +118.3% | +125.7% | +172.6% |
RCUS Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +166.7% | -33.3% | +107.7% | at high | +275.9% |
| 5 y | 5 years | at high | +166.7% | -33.3% | +2497.4% | at high | +275.9% |
| alltime | all time | at high | +508.8% | -33.3% | +2497.4% | at high | +1957.6% |
Arcus Biosciences Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $2.00 M(0.0%) | $10.00 M(+11.1%) |
| June 2024 | - | $2.00 M(-33.3%) | $9.00 M(0.0%) |
| Mar 2024 | - | $3.00 M(0.0%) | $9.00 M(+12.5%) |
| Dec 2023 | $8.00 M(+33.3%) | $3.00 M(+200.0%) | $8.00 M(+33.3%) |
| Sept 2023 | - | $1.00 M(-50.0%) | $6.00 M(-14.3%) |
| June 2023 | - | $2.00 M(0.0%) | $7.00 M(0.0%) |
| Mar 2023 | - | $2.00 M(+100.0%) | $7.00 M(+16.7%) |
| Dec 2022 | $6.00 M(+50.0%) | $1.00 M(-50.0%) | $6.00 M(-6.5%) |
| Sept 2022 | - | $2.00 M(0.0%) | $6.42 M(+19.3%) |
| June 2022 | - | $2.00 M(+100.0%) | $5.38 M(+28.1%) |
| Mar 2022 | - | $1.00 M(-29.4%) | $4.20 M(+5.0%) |
| Dec 2021 | $4.00 M(+33.3%) | $1.42 M(+47.1%) | $4.00 M(+50.4%) |
| Sept 2021 | - | $963.00 K(+17.4%) | $2.66 M(-1.4%) |
| June 2021 | - | $820.00 K(+2.5%) | $2.70 M(-4.2%) |
| Mar 2021 | - | $800.00 K(+939.0%) | $2.81 M(-6.2%) |
| Dec 2020 | $3.00 M | $77.00 K(-92.3%) | $3.00 M(-20.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2020 | - | $1.00 M(+6.7%) | $3.78 M(+3.1%) |
| June 2020 | - | $937.00 K(-5.0%) | $3.67 M(+1.5%) |
| Mar 2020 | - | $986.00 K(+15.2%) | $3.61 M(+0.9%) |
| Dec 2019 | $3.58 M(-2.3%) | $856.00 K(-3.4%) | $3.58 M(-2.5%) |
| Sept 2019 | - | $886.00 K(+0.3%) | $3.67 M(-2.3%) |
| June 2019 | - | $883.00 K(-7.3%) | $3.76 M(-0.8%) |
| Mar 2019 | - | $953.00 K(+0.6%) | $3.79 M(+3.4%) |
| Dec 2018 | $3.66 M(+40.3%) | $947.00 K(-2.8%) | $3.66 M(+5.2%) |
| Sept 2018 | - | $974.00 K(+6.4%) | $3.48 M(+7.5%) |
| June 2018 | - | $915.00 K(+10.5%) | $3.24 M(+9.7%) |
| Mar 2018 | - | $828.00 K(+8.1%) | $2.95 M(+13.1%) |
| Dec 2017 | $2.61 M(+98.8%) | $766.00 K(+4.6%) | $2.61 M(+41.5%) |
| Sept 2017 | - | $732.00 K(+16.6%) | $1.85 M(+65.7%) |
| June 2017 | - | $628.00 K(+29.2%) | $1.11 M(+129.2%) |
| Mar 2017 | - | $486.00 K | $486.00 K |
| Dec 2016 | $1.31 M | - | - |
FAQ
- What is Arcus Biosciences annual depreciation & amortization?
- What is the all time high annual D&A for Arcus Biosciences?
- What is Arcus Biosciences annual D&A year-on-year change?
- What is Arcus Biosciences quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Arcus Biosciences?
- What is Arcus Biosciences quarterly D&A year-on-year change?
- What is Arcus Biosciences TTM depreciation & amortization?
- What is the all time high TTM D&A for Arcus Biosciences?
- What is Arcus Biosciences TTM D&A year-on-year change?
What is Arcus Biosciences annual depreciation & amortization?
The current annual D&A of RCUS is $8.00 M
What is the all time high annual D&A for Arcus Biosciences?
Arcus Biosciences all-time high annual depreciation & amortization is $8.00 M
What is Arcus Biosciences annual D&A year-on-year change?
Over the past year, RCUS annual depreciation & amortization has changed by +$2.00 M (+33.33%)
What is Arcus Biosciences quarterly depreciation & amortization?
The current quarterly D&A of RCUS is $2.00 M
What is the all time high quarterly D&A for Arcus Biosciences?
Arcus Biosciences all-time high quarterly depreciation & amortization is $3.00 M
What is Arcus Biosciences quarterly D&A year-on-year change?
Over the past year, RCUS quarterly depreciation & amortization has changed by +$1.00 M (+100.00%)
What is Arcus Biosciences TTM depreciation & amortization?
The current TTM D&A of RCUS is $10.00 M
What is the all time high TTM D&A for Arcus Biosciences?
Arcus Biosciences all-time high TTM depreciation & amortization is $10.00 M
What is Arcus Biosciences TTM D&A year-on-year change?
Over the past year, RCUS TTM depreciation & amortization has changed by +$4.00 M (+66.67%)